Table 2.

Data for the CSF sterility at the 10 weeks follow-up

	Group I (AmB+	Group II (AmB +	P-value
	Fluconazole+ 5-FC,n = 27)	Fluconazole+ 5-FC + VPS, na = 38)
case (n, %)	8 (29.6%)	22 (56.4%)	0.033*
Daysb (mean ± SD)	29.2 ± 20.0	32.5 ± 24.8	0.909
≤ 2 weeks (n, %)	2 (7.4%)	8 (20.5%)	0.662
>  2 weeks (n, %)	6 (22.2%)	14 (35.9%)
≤ 4 weeks (n, %)	4 (14.8%)	13 (33.3%)	0.730
>  4 weeks (n, %)	4 (14.8%)	9 (23.1%)

AmB amphotericin B, 5-Fc flucytosine, Flu fluconazole, SD standard deviation. Continuous variables analyzed by t-test; categorical variables analyzed by chi-square test or Fisher’s exact test

^a One patient was lost to -follow-up at the 10th week in Group II

^b‘Days’ indicates the time from diagnosis to the first negative CSF india ink stain

^*P < 0.05